Christian S Schade - Net Worth and Insider Trading
Christian S Schade Net Worth
The estimated net worth of Christian S Schade is at least $845,308 dollars as of 2024-11-29. Christian S Schade is the Director of Integra Lifesciences Holdings Corp and owns about 32,633 shares of Integra Lifesciences Holdings Corp (IART) stock worth over $800,814. Christian S Schade is also the Chairman & CEO of Aprea Therapeutics Inc and owns about 14,931 shares of Aprea Therapeutics Inc (APRE) stock worth over $44,494. Details can be seen in Christian S Schade's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christian S Schade has not made any transactions after 2022-05-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christian S Schade
Christian S Schade Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christian S Schade owns 4 companies in total, including Integra Lifesciences Holdings Corp (IART) , Aprea Therapeutics Inc (APRE) , and NRG Energy Inc (NRG) among others .
Click here to see the complete history of Christian S Schade’s form 4 insider trades.
Insider Ownership Summary of Christian S Schade
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| IART | Integra Lifesciences Holdings Corp | 2019-05-10 | director |
| APRE | Aprea Therapeutics Inc | 2022-05-18 | director & President & CEO |
| NRG | NRG Energy Inc | 2011-01-03 | Exec VP & Chief Financial Ofc |
 | | 2023-07-10 | director |
Christian S Schade Latest Holdings Summary
Christian S Schade currently owns a total of 2 stocks. Among these stocks, Christian S Schade owns 32,633 shares of Integra Lifesciences Holdings Corp (IART) as of May 10, 2019, with a value of $800,814 and a weighting of 94.74%. Christian S Schade also owns 14,931 shares of Aprea Therapeutics Inc (APRE) as of May 18, 2022, with a value of $44,494 and a weighting of 5.26%.
Latest Holdings of Christian S Schade
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| IART | Integra Lifesciences Holdings Corp | 2019-05-10 | 32,633 | 24.54 | 800,814 |
| APRE | Aprea Therapeutics Inc | 2022-05-18 | 14,931 | 2.98 | 44,494 |
Holding Weightings of Christian S Schade
Christian S Schade Form 4 Trading Tracker
According to the SEC Form 4 filings, Christian S Schade has made a total of 0 transactions in Integra Lifesciences Holdings Corp (IART) over the past 5 years. The most-recent trade in Integra Lifesciences Holdings Corp is the sale of 15,658 shares on May 10, 2019, which brought Christian S Schade around $807,326.
According to the SEC Form 4 filings, Christian S Schade has made a total of 1 transactions in Aprea Therapeutics Inc (APRE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Aprea Therapeutics Inc is the acquisition of 1,875 shares on May 18, 2022, which cost Christian S Schade around $24,000.
Insider Trading History of Christian S Schade
- 1
Christian S Schade Trading Performance
GuruFocus tracks the stock performance after each of Christian S Schade's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christian S Schade is 78.8%. GuruFocus also compares Christian S Schade's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christian S Schade within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christian S Schade's insider trading performs compared to the benchmark.
Performance of Christian S Schade
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 23.7 | | | | | |
| Relative Return to S&P 500(%) | 24.38 | | | | | |
Christian S Schade Ownership Network
Christian S Schade Owned Company Details
What does Integra Lifesciences Holdings Corp do?
Who are the key executives at Integra Lifesciences Holdings Corp?
Christian S Schade is the director of Integra Lifesciences Holdings Corp. Other key executives at Integra Lifesciences Holdings Corp include SVP & Fin & PAO Jeffrey Mosebrook , director & President and CEO Stuart Essig , and Corp VP & Pres. Neurosurgery Davis Robert T. Jr. .
Integra Lifesciences Holdings Corp (IART) Insider Trades Summary
Over the past 18 months, Christian S Schade made no insider transaction in Integra Lifesciences Holdings Corp (IART). Other recent insider transactions involving Integra Lifesciences Holdings Corp (IART) include a net sale of 2,368 shares made by Jeffrey Mosebrook , a net purchase of 52,641 shares made by Stuart Essig , and a net purchase of 36,350 shares made by Barbara B Hill .
In summary, during the past 3 months, insiders sold 0 shares of Integra Lifesciences Holdings Corp (IART) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 10,716 shares of Integra Lifesciences Holdings Corp (IART) were sold and 99,423 shares were bought by its insiders, resulting in a net purchase of 88,707 shares.
Integra Lifesciences Holdings Corp (IART)'s detailed insider trading history can be found in Insider Trading Tracker table.
Integra Lifesciences Holdings Corp Insider Transactions
Christian S Schade Mailing Address
Above is the net worth, insider trading, and ownership report for Christian S Schade. You might contact Christian S Schade via mailing address: Medarex, 707 State Road, Princeton Nj 08540.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
